HeadlessHorsemen
Posted - 1 day ago
$DVAX New Year's BoD's Resolution: The CEO is not our friend. He is an employee. You can be friendly, but not friends. The BoD's responsibility is to the Company and its Stock Holders. If the CEO is not preforming his responsibilities, then he needs to be replaced. Just business, nothing personal. If the BoD is not capable of performing the basic two functions listed above, then the Board must resign.
AccuRoger
Posted - 1 day ago
$DVAX The Biden administration granted a small $11 million to CEIRR today for H1N5 medical research (Bird Flu). DVAX and Mount Sinai are already on their radar. https://www.ceirr-network.org/resources/publications
KWalzz
Posted - 3 days ago
$DVAX the "no PR available" company ...
KWalzz
Posted - 3 days ago
$DVAX the "no management available" company ...
AccuRoger
Posted - 3 days ago
$DVAX Here is ANOTHER HIV human trial with a Completion Date at the end of February that is using CpG 1018. At the last analyst call, management specifically said that they do not discuss preclinical or Phase I studies. Why not?
Investors are not paying for these studies, but there is a clear involvement in the HIV space. Management has not yet acknowledged that Heplisav was given preference by the CDC for patients dealing with HIV.
Fundamental Analysis is a helpful investment approach. DVAX has the potential to expand worldwide and add other vaccines organically. They do not need to bolt on another company; yet, that is a repeated refrain. I can criticize management without peppering my comments with worthless insults. Try it, you’ll like it. And, the value of posts on this message board will increase. https://clinicaltrials.gov/study/NCT06541093?intr=Cpg%201018&aggFilters=status:not%20rec%20act&sort=StudyFirstPostDate&rank=1
KWalzz
Posted - 12/31/24
$DVAX the 8K from December, 27th went unnoticed by all pumpers here 🤣 ... it's related to the Deep Track Capital activism I think (or fear?) ... no one knows exactly what's going on, but management is still not able to do regular PR, no one interested in this shit co, will 2025 bring change? I doubt it but would profit much ... let's find out 2025 - management will change its way for sure because
HeadlessHorsemen
Posted - 12/30/24
$DVAX Well, a Merry Christmas to us from our infamously incompetent CEO and BoD. We had a couple of days at $13 with sugar plums dancing in our heads and just like that with Santa Claus retreating back to the North Pole it is now back to reality for 2025 and there are no 12 drummers drumming.
KWalzz
Posted - 12/30/24
$DVAX will it explode at last after all the fantastic science news of past months, wait, even years? we will see .... yawn.
AccuRoger
Posted - 12/29/24
$DVAX There are now TWO studies using Heplisav in combination with TheraVacB as a therapeutic for chronic HepB infection. The first, NCT05727267, started a year ago with a Primary Completion Date of February 2025. Subjects were healthy volunteers in Germany. The second is posted to start in January 2025 using subjects diagnosed with chronic HepB
Infection. It is Phase I/II. My official projection is that the earlier study has encouraging results. We could end up in the prevention and the treatment parts of the business. The current therapies are terrible. Happy New Year.
Buy_dvax100
Posted - 12/26/24
$DVAX
NVDAMillionaire
Posted - 12/24/24
$DVAX Dynavax Technologies (DVAX): Pioneering Vaccines to Protect Against Infectious Diseases https://beyondspx.com/article/dynavax-technologies-dvax-pioneering-vaccines-to-protect-against-infectious-diseases
KWalzz
Posted - 12/20/24
$DVAX 4 cents down .... merry xmas.
Buy_dvax100
Posted - 12/20/24
$DVAX
Doozio
Posted - 12/20/24
$DVAX any data due soon here? Appears ready FOUR goin INTA 🧠⏰♾️ with an XBI bahhhtom.
AccuRoger
Posted - 12/19/24
$DVAX On January 8 2024 and January 9 2023, management released preliminary financial results for Q4 via PR only with limited comment. The full details were presented in mid-February. Do not hold your breath in 2025, but do not be surprised should it happen again. No rationale for the early notice was given. So, there is no way to predict. Enjoy family and friends all Christmas week. Celebrate the True meaning of the holiday.
KWalzz
Posted - 12/18/24
$DVAX
GeniusAlep
Posted - 12/18/24
@VictorJung Hi Victor, good times in $DVAX!!! Best regards ✌️Marry Christmas from Italy
Noobnr1
Posted - 12/17/24
$DVAX BO comming 😀🚀 In my dreams i guess
KWalzz
Posted - 12/17/24
$DVAX 5 cents up ... very good.
KWalzz
Posted - 12/17/24
$DVAX Ben, kudos to your theory that "will make DVAX an acquisition target". Excuse me when I say that I think your statements about "Dvax isn’t a vaccine company" and "Kennedy will open the door for hepislav and CPG in the childhood vax" are so far from reality. I really struggle to find further words for this. And I fear absolutely nothing of this will materialize, but what I really like about your theory is that it will eventually attract enough investors to drive this stock up to 15, my declared "out-of-this-shit-co" price target. Thank you for this if it ever materializes!
AccuRoger
Posted - 12/17/24
$DVAX This NIAID sponsored Phase I HIV vaccine trial using CpG 1018 completed in November. Data should be reported in next few months. The sponsor needs to give DVAX permission to PR updates; I do not blame management for silence on this one. Quote
Experimental: Part B, Group 3 (T3): BG505 SOSIP.664 gp140 + CpG 1018 + Alum
Participants will receive 100 mcg of BG505 SOSIP.664 gp140, admixed with 300 mcg of CpG 1018 and 500 mcg of Alum, as one IM injection at Months 0, 2, and 6.
https://clinicaltrials.gov/study/NCT04177355
VictorJung
Posted - 12/17/24
@GeniusAlep man you made the right move pulling out of $DVAX and going all in here. Kudos, wish i wouldve followed your lead
Pegger
Posted - 12/16/24
$DVAX The article from gurufocus is pure nonsense. Dynavax put in place its stockholders rights plan in “response to the recent rapid accumulations of stock by Deep Track Capital, which recently disclosed in a Schedule 13D/A filing its ownership of 13.6% of the Company's outstanding common stock.” The article from gurufocus stating Deep Track sold its holdings is dated prior to Dynavax initiating the shareholders rights plan. There seems to be a concerted effort to provide misinformation on Dynavax with the objective of suppressing the share price. Ignore the noise. Know what you own. Long shareholders will be rewarded (all in my humble opinion)
benTHEbroker
Posted - 12/16/24
$DVAX final thought.. this will make DVAX an acquisition target for any vaccine companies looking to hedge against alum getting the boot.
benTHEbroker
Posted - 12/16/24
$DVAX Kennedy will open the door for hepislav and CPG in the childhood vax market which is 90% of the TAM. DVAX Execs need to be all over this
direct quote from Kennedy:
We need to do double-blind placebo testing. Because particularly when it comes to injecting aluminum or mercury into babies, the consequences may be latent. In other words, they may not manifest or diagnosed to age 3 or 4. So the current protocols, which require testing for vaccines of sometimes as little as 48 hours, are not going to disclose the kind of dangers that the public and the regulators ought to know about.
The hepatitis B vaccines that are currently approved had fewer than five days of safety testing. That means that if the child has a seizure on the sixth day, it’s never seen. If the child dies, it’s never seen. If the child gets food allergies or ADD or ADHD, which don’t manifest for four or five years or aren’t diagnosed or autism, which usually isn’t diagnosed until age 4
benTHEbroker
Posted - 12/16/24
$DVAX Dvax isn’t a vaccine company, it’s an adjuvant company. Hepislav B was a proof of concept that it can make existing vaccines more effective. They’ve since been in covid, there’s studies for TDAP, plague, many more. Alum is also an adjuvant, one that many don’t want in vaccines because of LT side effects. Alum is in basically all mandatory legacy vaccines. If Alum were to be banned, there would be an opportunity for CPG to replace it. Those are huge markets, even just for Hepislav… image acces to childhood market. There’s a huge upside potential here if they play it right.
KWalzz
Posted - 12/15/24
$DVAX everybody knows that there is no alum in heplisav-b because cpg is used as adjuvant. what a "new" fact for a decade or so, will it at last bring us back to 21? I think not because of our incompetent CEO and because of the fact that dvax is a one-vaccine-only and else-totally-boring company.
AccuRoger
Posted - 12/14/24
$DVAX The fact is Heplisav-B DOES NOT contain Alum or Aluminum Salts. Instead, Alum was added to the COVID vaccines. All sold outside the USA. In theory, RFK might eliminate our GSK competitor. Search for ingredients using this link:
https://www.fda.gov/media/108745/download#:~:text=HEPLISAV%2DB%20is%20prepared%20by,%2C%200.48%20mg%2FmL%3B%20and
